Sign in
4

Changes in Ownership

Xilio Therapeutics, Inc. Filed Acc 0001062993-25-011170

Options or other derivatives

  • 10% owner bought 53,340,000 shares

From the SEC's structured data for this filing

Trades in this filing

GILEAD SCIENCES, INC. · 10% owner

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2025-06-05 Purchase : show line 1 in the form Prefunded Warrants (right to buy) +13,335,000 23,310,266 D
2025-06-05 Purchase : show line 2 in the form Series A Warrants (right to buy) +13,335,000 13,335,000 D
2025-06-05 Purchase : show line 3 in the form Series B Warrants (right to buy) +13,335,000 13,335,000 D
2025-06-05 Purchase : show line 4 in the form Series C Warrants (right to buy) +13,335,000 13,335,000 D
Loading xslF345X05/form4.xml…